CarMax Reports 50% EPS Decline, $141M Goodwill Impairment, Pauses Share Buybacks Amidst Challenging Market
KMX sits 36% above its 52-week low of $30.26.
Summary
CarMax reported a significant 50.6% decline in net earnings and a $141.3 million goodwill impairment for fiscal 2026, alongside a pause in share repurchases and an increase in its SG&A reduction target.
Key Events · Earnings and Guidance · KMX
-
Significant Earnings Decline
Net earnings fell 50.6% to $247.3 million, with diluted EPS dropping 47.7% to $1.68 for fiscal 2026, confirming the preliminary Q4 results announced on 2026-04-14.
-
Goodwill Impairment Recorded
The company recorded a $141.3 million non-cash goodwill impairment charge in Q4 fiscal 2026, driven by a significant decline in market capitalization and pressured financial performance.
-
Share Buyback Program Paused
CarMax paused its share repurchase program during the fourth quarter of fiscal 2026, citing leverage slightly above its targeted range, a new material disclosure regarding capital allocation.
-
Increased Cost Reduction Target
The company raised its SG&A exit rate savings goal to $200 million by the end of fiscal 2027, an increase from its previous target of $150 million, reflecting intensified cost control efforts.
Analysis · KMX · Trade & Services
CarMax's 10-K filing details a challenging fiscal 2026, marked by a substantial decline in profitability and a significant non-cash goodwill impairment. The decision to pause share repurchases, a new disclosure, signals management's focus on balance sheet health and capital preservation amidst operational pressures. While the increased SG&A reduction target indicates proactive cost management, the overall financial performance and the newly disclosed class action lawsuit present considerable headwinds. Investors should monitor the effectiveness of the new CEO's strategy, the progress on cost savings, and the resolution of the legal proceedings.
At the time of this filing, KMX was trading at $41.17 on NYSE in the Trade & Services sector, with a market capitalization of approximately $5.8B. The 52-week trading range was $30.26 to $71.99. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.